Cellyan Biotechnology Co., Ltd (HKPD) Sentiment Analysis
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
- ST sentiment gradeHow the market currently feels about this stock versus its peers
- —
- Overall ST grade
- C-
- ST Score
- 32.2
- Price change today
- —
- Strong buy
- —
- Buy
- —
- Hold
- —
- Sell
- —
- Strong sell
- —
- Bullish share0 bullish vs 0 bearish ratings
- —
Headline tone is a simple keyword scan of recent coverage, not a prediction.
HKPD stock: frequently asked questions
What is HKPD's ST Score?
Cellyan Biotechnology Co., Ltd (HKPD) has an ST Score of 32.2 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is HKPD a buy, hold, or sell?
Our ST Score grades it C- (32.2/100). The ST Score is a data-driven signal, not a recommendation.
What are HKPD's factor grades?
Valuation B+, Profitability D, Financial Strength B, Momentum F, Growth F.
What is HKPD's valuation grade?
Cellyan Biotechnology Co., Ltd (HKPD) earns a valuation grade of B+, measured against Medical - Distribution peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is HKPD's growth grade?
Cellyan Biotechnology Co., Ltd (HKPD) earns a growth grade of F, measured against Medical - Distribution peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is HKPD's profitability grade?
Cellyan Biotechnology Co., Ltd (HKPD) earns a profitability grade of D, measured against Medical - Distribution peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is HKPD's financial strength grade?
Cellyan Biotechnology Co., Ltd (HKPD) earns a financial strength grade of B, measured against Medical - Distribution peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is HKPD's Piotroski score?
Cellyan Biotechnology Co., Ltd (HKPD) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.